Microangiopathic hemolytic anemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 51: Line 51:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* In specific [[viral]] [[disease]]s like [[Dengue]] hemorrhagic fever, [[hantavirus]] and [[filoviridae]], there is significant [[thrombocytopenia]].  
* In specific [[viral]] [[disease]]s like [[Dengue]] hemorrhagic fever, [[hantavirus]] and [[filoviridae]], there is significant [[thrombocytopenia]].  
* Patients have a recent history of travel.  
* [[Patient]]s have a recent history of travel.  
* There are no signs of [[hemolysis]] on laboratory workup.
* There are no signs of [[hemolysis]] on laboratory workup.
|}
|}

Revision as of 20:49, 28 January 2021

Microangiopathic hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microangiopathic hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microangiopathic hemolytic anemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microangiopathic hemolytic anemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microangiopathic hemolytic anemia differential diagnosis

on Microangiopathic hemolytic anemia differential diagnosis

Microangiopathic hemolytic anemia differential diagnosis in the news

Blogs on Microangiopathic hemolytic anemia differential diagnosis

Directions to Hospitals Treating Microangiopathic hemolytic anemia

Risk calculators and risk factors for Microangiopathic hemolytic anemia differential diagnosis

Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]


Microangiopathic hemolytic anemia must be differentiated from following diseases[1]:

Disease Findings
Pseudo-TTP (Vitamin B12 deficiency)
Pregnancy induced fatty liver
Disseminated intravascular coagulation
Endocarditis
Evan's syndrome
Antiphospholipid syndrome
Malaria, Babesiosis
Viral Infections


References

  1. Bommer M, Wölfle-Guter M, Bohl S, Kuchenbauer F (2018). "The Differential Diagnosis and Treatment of Thrombotic Microangiopathies". Dtsch Arztebl Int. 115 (19): 327–334. doi:10.3238/arztebl.2018.0327. PMC 5997890. PMID 29875054.
  2. Ko H, Yoshida EM (2006). "Acute fatty liver of pregnancy". Can J Gastroenterol. 20 (1): 25–30. doi:10.1155/2006/638131. PMC 2538964. PMID 16432556.

Template:WH Template:WS